Emerging treatments
Novel antiviral compounds
Given the scarce evidence for efficacy of ribavirin (the only approved therapy for RSV), a therapy with clear efficacy would be a welcome breakthrough. Several antiviral compounds are in clinical development.[142] These include therapies blocking RSV fusion protein (RSV-F) , inhibiting viral polymerase (RSV-L), or other central viral proteins (RSV-N , RSV-M2). These therapies are at various stages of clinical development.[30][86][143][144]
Use of this content is subject to our disclaimer